The FDA's CDRH issued guidance, effective immediately, detailing new requirements for medical device manufacturers to notify it of shortages during the COVID-19 pandemic.
Historically, only drug manufacturers have been required to report shortages or discontinuances of their products to FDA.
![Medical Device in use](https://static.wixstatic.com/media/11062b_88f0f8bb2c89414e9901da5008ec1a1a~mv2.jpg/v1/fill/w_980,h_653,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/11062b_88f0f8bb2c89414e9901da5008ec1a1a~mv2.jpg)
However, the newly passed CARES Act (Coronavirus Aid, Relief, and Economic Security Act) included new requirements for medical device manufacturers.
Specifically, manufacturers are now required to provide notice at least 6 months ahead of the discontinuance or interruption, for critical devices used during a declared public health emergency or devices deemed necessary by FDA.
Comments